Inhalerx Ltd
ASX:IRX
Cash Flow Statement
Cash Flow Statement
Inhalerx Ltd
| Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Stock-Based Compensation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Taxes Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Change in Working Capital |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Cash from Operating Activities |
(1)
N/A
|
(1)
+3%
|
(1)
-13%
|
(2)
-34%
|
(2)
-20%
|
(3)
-38%
|
(2)
+23%
|
(0)
+80%
|
(0)
+6%
|
|
| Investing Cash Flow | ||||||||||
| Capital Expenditures |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
|
| Other Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Investing Activities |
(0)
N/A
|
(0)
-223%
|
(0)
-81%
|
(0)
+44%
|
(0)
+99%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Financing Cash Flow | ||||||||||
| Net Issuance of Common Stock |
2
|
4
|
2
|
(0)
|
1
|
0
|
0
|
0
|
0
|
|
| Net Issuance of Debt |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
(0)
|
|
| Other |
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
|
| Cash from Financing Activities |
2
N/A
|
4
+70%
|
2
-44%
|
0
N/A
|
1
N/A
|
1
0%
|
1
-54%
|
0
-63%
|
(0)
N/A
|
|
| Change in Cash | ||||||||||
| Effect of Foreign Exchange Rates |
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
|
| Net Change in Cash |
1
N/A
|
3
+129%
|
1
-63%
|
(2)
N/A
|
(1)
+57%
|
(1)
-104%
|
(1)
-4%
|
(0)
+86%
|
(1)
-169%
|
|
| Free Cash Flow | ||||||||||
| Free Cash Flow |
(1)
N/A
|
(1)
+2%
|
(1)
-14%
|
(2)
-33%
|
(2)
-19%
|
(3)
-38%
|
(2)
+23%
|
(0)
+80%
|
(0)
+6%
|
|